- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Trial Phase
Trial Status
Paid Participation
Clear All
Trial Details
Key Eligibility Criteria
600 Participants Needed
Trial Details
Key Eligibility Criteria
398 Participants Needed
Trial Details
Key Eligibility Criteria
1538 Participants Needed
Trial Details
Key Eligibility Criteria
5500 Participants Needed
Trial Details
Key Eligibility Criteria
1209 Participants Needed
Trial Details
Key Eligibility Criteria
3960 Participants Needed
Trial Details
Key Eligibility Criteria
1295 Participants Needed
Trial Details
Key Eligibility Criteria
838 Participants Needed
Trial Details
Key Eligibility Criteria
474 Participants Needed
Trial Details
Key Eligibility Criteria
1912 Participants Needed
Trial Details
Key Eligibility Criteria
82 Participants Needed
Trial Details
Key Eligibility Criteria
2050 Participants Needed
Trial Details
Key Eligibility Criteria
1670 Participants Needed
Trial Details
Key Eligibility Criteria
200 Participants Needed
Trial Details
Key Eligibility Criteria
2753 Participants Needed
Trial Details
Key Eligibility Criteria
330 Participants Needed
Trial Details
Key Eligibility Criteria
1031 Participants Needed
Trial Details
Key Eligibility Criteria
138 Participants Needed
Trial Details
Key Eligibility Criteria
352 Participants Needed
Trial Details
Key Eligibility Criteria
1210 Participants Needed
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
Trial Details
Key Eligibility Criteria
168 Participants Needed
Trial Details
Key Eligibility Criteria
300 Participants Needed
Trial Details
Key Eligibility Criteria
668 Participants Needed
Trial Details
Key Eligibility Criteria
455 Participants Needed
Trial Details
Key Eligibility Criteria
635 Participants Needed
Trial Details
Key Eligibility Criteria
363 Participants Needed
Trial Details
Key Eligibility Criteria
384 Participants Needed
Trial Details
Key Eligibility Criteria
813 Participants Needed
Trial Details
Key Eligibility Criteria
10000 Participants Needed
Trial Details
Key Eligibility Criteria
544 Participants Needed
Know someone looking for new options?
Spread the word
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across trials in Gettysburg, PA 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Gettysburg, PA is 12 months.
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Gettysburg, PA several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
Most recently, we added Cemiplimab for Non-Small Cell Lung Cancer, Radiation Therapy for Brain Metastasis and Amivantamab for Non-Small Cell Lung Cancer to the Power online platform.